The US inhalable drug market is anticipated to grow at a CAGR of 2.3% during the forecast period (2020-2026). The key factors driving the growth of the market include the rising prevalence of various respiratory and non- respiratory diseases in the country. The prevalence of asthma in the US is 1 in every 13 people. Over 25 million Americans are likely to have asthma, as of 2018, representing 7.7% of adults and 8.4% of children. Other factors that fuel the market growth in the country is increasing geriatric population and availability of a wide range of treatment option to choose from. Besides, a sedentary lifestyle along with unhealthy eating habits such as smoking, which is a prime factor for the increasing prevalence of several respiratory diseases such as COPD and asthma. The aforementioned factors create demand for inhalable drugs and hence drives the growth of the market in the country. 

The US inhalable drug market has been segmented on the basis of the application and route of administration. Based on the application, the market is bifurcated into respiratory disease and non-respiratory diseases. The respiratory disease segment is likely to hold a significant share over the forecast period. Based on the route of administration, the market is segmented into the nasal inhalable drug and mouth inhalable drugs. The mouth segment is likely to contribute a significant share over the forecast period.  

Further, Novartis International AG, GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Bausch Health Companies Inc., and TFF Pharmaceuticals, Inc. are some of the prominent players covered in the US inhalable drugs market report. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players in order to sustain in the highly competitive market. 

Research Methodology

The market study of the US inhalable drug market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report is intended for pharmaceutical companies, drug manufacturers, research institutes, government organizations, regulatory bodies, industry associates & experts, other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. US Inhalable Drugs Market Research and Analysis by Application
2. US Inhalable Drugs Market Research and Analysis by Route of Administration

The Report covers:

• Comprehensive research methodology of the US Inhalable Drugs market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US Inhalable Drugs market.
• Insights about market determinants which are stimulating the US Inhalable Drugs market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of the market players.